32 phenotypes from 2 alleles in 3 genetic backgrounds

Allelic Composition Genetic Background	Annotated Term	Reference
Dmxl2tm1a(EUCOMM)Wtsi/Dmxl2+ C57BL/6N-Atm1Brd Dmxl2tm1a(EUCOMM)Wtsi/WtsiH	decreased bone mineral content	J:211773
	decreased circulating cholesterol level	J:211773
	decreased lean body mass	J:211773
	increased total body fat amount	J:211773
Dmxl2tm1a(EUCOMM)Wtsi/Dmxl2+ involves: C57BL/6N	no abnormal phenotype detected	J:217623
Dmxl2tm1a(EUCOMM)Wtsi/Dmxl2tm1a(EUCOMM)Wtsi C57BL/6N-Atm1Brd Dmxl2tm1a(EUCOMM)Wtsi/WtsiH	abnormal ductus venosus valve morphology	J:239583
	abnormal vertebral artery morphology	J:239583
	blood in lymph vessels	J:239583
	embryo tumor	J:239583
	multiple persisting craniopharyngeal ducts	J:239583
	no abnormal phenotype detected	J:239583
	preweaning lethality, complete penetrance	J:211773
Dmxl2tm1a(EUCOMM)Wtsi/Dmxl2tm1a(EUCOMM)Wtsi involves: C57BL/6N	prenatal lethality, complete penetrance	J:217623
Dmxl2tm1c(EUCOMM)Wtsi/Dmxl2+ Tg(Nes-cre)1Atp/0 involves: C57BL/6N * FVB/N	abnormal estrous cycle	J:217623
	abnormal hypothalamus morphology	J:217623
	abnormal hypothalamus secretion	J:217623
	decreased body weight	J:217623
	decreased circulating testosterone level	J:217623
	decreased corpora lutea number	J:217623
	decreased ovary weight	J:217623
	decreased ovulation rate	J:217623
	decreased testis weight	J:217623
	delayed estrous cycle	J:217623
	delayed sexual maturation	J:217623
	delayed vaginal opening	J:217623
	normal homeostasis/metabolism phenotype	J:217623
	increased circulating luteinizing hormone level	J:217623
	increased exploration in new environment	J:217623
	reduced female fertility	J:217623
	reduced fertility	J:217623
	reduced male fertility	J:217623
	short perineum	J:217623
	short proestrus	J:217623